The Protein Brewery Secures €18M to Enter the European Market

The Protein Brewery, a Dutch food ingredients company, has secured €18 million in funding to expand its production capacity and enter the European market. This funding comes after receiving EU Novel Food authorization for its mycoprotein ingredient Fermotein, which contains 50% protein with a complete amino acid profile, 30% dietary fiber, and various micronutrients. The company plans to market Fermotein in Europe starting in the summer of 2026, focusing on active nutrition products like powders and bars, as well as functional foods and beverages.

Led by new investor ABN AMRO Sustainable Impact Fund, the funding will also support The Protein Brewery's efforts to conduct clinical research into Fermotein's health benefits and pursue regulatory approvals in Canada, Australia, New Zealand, and India. The company has already sold its entire 2026 production capacity to customers in the US, with a growing pipeline of active nutrition customers in the EU and UK. With this funding, The Protein Brewery aims to deliver Fermotein on a larger scale to meet the challenges of feeding a growing population with fewer environmental resources.